Charter operates an ISO/IEC 17025-aligned quality management system. While we are not formally accredited at this time, every procedure follows the principles required for accreditation, and our records are maintained in audit-ready format.
Charter maintains a written QMS with the following SOPs:
SOPs are available for review by client auditors under NDA.
Every Charter report carries an authentication ID (format CB-2026-XXXXXX-XXXX) that ties the report to:
The full audit trail for any report is available to the report-owner client on request, free of charge.
Test records, including raw chromatograms, instrument logs, and the signed report PDF, are retained for a minimum of 7 years. Sample retains are kept for 1 year. Calibration records and method-validation records are retained for the lifetime of the relevant method plus 7 years.
Charter Bioanalytics performs analytical chemistry on samples submitted by clients. Charter does not certify, guarantee, or warrant any therapeutic, diagnostic, or preventative property of any compound analyzed. Charter reports are not, and shall not be construed as, FDA approval, clearance, or endorsement of any product. The compounds analyzed are research chemicals not for human or animal consumption unless otherwise authorized by a regulatory body.
Out-of-specification or unexpected results trigger Charter's OOS investigation procedure (SOP-050) before a report is released. Investigations may include re-injection, retain re-analysis, or repeat testing. The full investigation outcome is documented in the report's audit trail.
If a client believes a Charter result is in error, contact us at support@charterbioanalytics.com and we will open a formal investigation. Investigations are completed within 10 business days.